Ultrasonic features of papillary thyroid microcarcinoma and non-microcarcinoma

Zhang,Xiao-Li; Qian,Lin-Xue

doi:10.3892/etm.2014.1910

Ultrasonic features of papillary thyroid microcarcinoma and non-microcarcinoma

Authors:
- Xiao-Li Zhang
- Lin-Xue Qian
View Affiliations

Affiliations: Department of Ultrasound, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing 100050, P.R. China
Published online on: August 18, 2014 https://doi.org/10.3892/etm.2014.1910
Pages: 1335-1339

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study analyzed the ultrasonic features of papillary thyroid microcarcinoma (PTMC) and papillary thyroid non‑microcarcinoma (non‑PTMC) with the aim of improving the diagnostic value of ultrasonography. The ultrasonic features of 328 patients with papillary thyroid carcinoma (PTC), as confirmed by pathology, were retrospectively analyzed. Patients were diagnosed with PTMC if the tumor size was ≤10 mm in diameter or non‑PTMC if the tumor size was >10 mm in diameter. The shape, ratio of length/width, boundary, echo, peripheral halo ring, calcification, cystic changes, blood flow, lymph node metastasis and additional accompanying thyroid diseases were compared between the patients with PTMC and non‑PTMC. In total, 389 nodules were identified in the 328 patients, including 209 PTMC nodules and 180 non‑PTMC nodules. The multifocality rate was 15.9% (52/328). Ultrasound scans detected a total of 371 nodules, while 18 PMTC nodules were missed diagnosed and 57 nodules were misdiagnosed as benign nodules. Statistically significant differences in the boundary, ratio of length/width, cystic changes, blood flow and lymph node metastasis were observed between the PTMC and non‑PTMC groups (P<0.05). However, no statistically significant differences were observed with regard to the shape, calcification, peripheral halo rings and additional accompanying thyroid diseases between the two groups (P>0.05). Therefore, ultrasound plays an important role in the diagnosis of PTC, with PTMC and non‑PTMC exhibiting different ultrasonic performances.

View Figures

View References

1	Londero SC, Krogdahl A, Bastholt L, et al: Papillary thyroid carcinoma in Denmark 1996–2008: an investigation of changes in incidence. Cancer Epidemiol. 37:e1–e6. 2013.
2	Ito Y and Miyauchi A: A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab. 3:240–248. 2007. View Article : Google Scholar : PubMed/NCBI
3	Sakorafas GH, Giotakis J and Stafyla V: Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev. 31:423–438. 2005. View Article : Google Scholar : PubMed/NCBI
4	Arora N, Turbendian HK, Kato MA, Moo TA, Zarnegar R and Fahey TJ III: Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid. 19:473–477. 2009. View Article : Google Scholar : PubMed/NCBI
5	Lee HS, Park HS, Kim SW, et al: Clinical characteristics of papillary thyroid microcarcinoma less than or equal to 5 mm on ultrasonography. Eur Arch Otorhinolaryngol. 270:2969–2974. 2013. View Article : Google Scholar : PubMed/NCBI
6	Anil G, Hegde A and Chong FH: Thyroid nodules: risk stratification for malignancy with ultrasound and guided biopsy. Cancer Imaging. 11:209–223. 2011.PubMed/NCBI
7	Page C, Biet A, Boute P, et al: ‘Aggressive papillary’ thyroid microcarcinoma. Eur Arch Otorhinolaryngol. 266:1959–1963. 2009.
8	DeLellis RA, Lloyd RV, Heitz PU and Eng C: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. 8. IARC Press; Lyon: 2004
9	Adler DD, Carson PL, Rubin JM and Quinn-Reid D: Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings. Ultrasound Med Biol. 16:553–559. 1990. View Article : Google Scholar : PubMed/NCBI
10	Pazaitou-Panayiotou K, Capezzone M and Pacini F: Clinical features and therapeutic implication of papillary thyroid microcarcinoma. Thyroid. 17:1085–1092. 2007. View Article : Google Scholar : PubMed/NCBI
11	Londero SC, Krogdahl A, Bastholt L, et al: Papillary thyroid microcarcinoma in Denmark 1996–2008: a national study of epidemiology and clinical significance. Thyroid. 23:1159–1164. 2013.PubMed/NCBI
12	Antonaci A, Consorti F, Mardente S, Natalizi S, Giovannone G and Della Rocca C: Survivin and cyclin D1 are jointly expressed in thyroid papillary carcinoma and microcarcinoma. Oncol Rep. 20:63–67. 2008.PubMed/NCBI
13	Park YJ, Kim YA, Lee YJ, et al: Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings. Head Neck. 32:38–45. 2010.
14	Noguchi S, Yamashita H, Uchino S and Watanabe S: Papillary microcarcinoma. World J Surg. 32:747–753. 2008. View Article : Google Scholar
15	Mazeh H, Samet Y, Hochstein D, et al: Multifocality in well-differentiated thyroid carcinomas calls for total thyroidectomy. Am J Surg. 201:770–775. 2011. View Article : Google Scholar : PubMed/NCBI
16	Kuo SF, Lin SF, Chao TC, Hsueh C, Lin KJ and Lin JD: Prognosis of multifocal papillary thyroid carcinoma. Int J Endocrinol. 2013:8093822013.PubMed/NCBI
17	Kuhn E, Teller L, Piana S, Rosai J and Merino MJ: Different clonal origin of bilateral papillary thyroid carcinoma, with a review of the literature. Endocr Pathol. 23:101–107. 2012. View Article : Google Scholar : PubMed/NCBI
18	Wang Y, Li L, Wang YX, Feng XL, et al: Ultrasound findings of papillary thyroid microcarcinoma: a review of 113 consecutive cases with histopathologic correlation. Ultrasound Med Biol. 38:1681–1688. 2012. View Article : Google Scholar : PubMed/NCBI
19	Park JM, Choi Y and Kwag HJ: Partially cystic thyroid nodules: ultrasound findings of malignancy. Korean J Radiol. 13:530–535. 2012. View Article : Google Scholar : PubMed/NCBI
20	Trimboli P, Nasrollah N, Amendola S, et al: Should we use ultrasound features associated with papillary thyroid cancer in diagnosing medullary thyroid cancer? Endocr J. 59:503–508. 2012. View Article : Google Scholar : PubMed/NCBI
21	Das DK, Sheikh ZA, George SS, Al-Baquer T and Francis IM: Papillary thyroid carcinoma: evidence for intracytoplasmic formation of precursor substance for calcification and its release from well-preserved neoplastic cells. Diagn Cytopathol. 36:809–812. 2008. View Article : Google Scholar
22	Lun Y, Wu X, Xia Q, et al: Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol Head Neck Surg. 148:396–402. 2013.
23	Jankovic B, Le KT and Hershman JM: Clinical Review: Hashimoto’s thyroiditis and papillary thyroid carcinoma: is there a correlation? J Clin Endocrinol Metab. 98:474–482. 2013.
24	Flanagan JN, Pineda P, Knapp PE, De Las Morenas A, Lee SL and Braverman LE: Expression of cytokeratin 19 in the diagnosis of thyroid papillary carcinoma by quantitative polymerase chain reaction. Endocr Pract. 14:168–174. 2008. View Article : Google Scholar : PubMed/NCBI